KLHL6: A Potential Drug Target and Biomarker (G89857)

Target Name: KLHL6

NCBI ID: G89857

KLHL6

Other Name(s): kelch like family member 6 | Kelch-like protein 6 | KLHL6_HUMAN | Kelch like family member 6 | Kelch-like protein KLHL6

KLHL6: A Potential Drug Target and Biomarker

Kelch-like family member 6 (KLHL6) is a non-coding RNA molecule that has been identified in various organisms, including humans. Its function and structure have not yet been fully understood, but recent studies have suggested that it may play a significant role in various biological processes. As a result, KLHL6 has potential as a drug target and biomarker.

The Kelch-like family of proteins is a group of cytoplasmic proteins that contain a characteristic domain known as the kelch domain. This domain is responsible for the protein's ability to interact with various ligands, including small molecules, ions, and proteins. The KLHL6 protein is a member of this family and has been identified in various organisms, including plants, animals, and bacteria.

One of the most significant features of KLHL6 is its ability to interact with small molecules, such as drugs. This interaction is mediated by the protein's kelch domain, which is known to be involved in the protein's catalytic and structural functions. Several studies have suggested that KLHL6 can be a drug target, with potential for the development of inhibitors that can treat various diseases.

KLHL6's potential as a drug target is based on its unique ability to interact with small molecules, as well as its structure and function. The kelch domain of KLHL6 is known to be involved in the protein's catalytic and structural functions, which may make it a useful target for small molecule inhibitors. Additionally, the protein's structure and function have led to the prediction that it may have various functions in various biological processes, including signaling, DNA replication, and metabolism.

In addition to its potential as a drug target, KLHL6 has also been identified as a potential biomarker. The protein is expressed in various tissues and cells in the body, including the brain, heart, and liver, and has been shown to be involved in various biological processes. Several studies have suggested that KLHL6 may be a useful biomarker for the diagnosis and treatment of various diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

The potential of KLHL6 as a drug target and biomarker is still being explored, but its identification and characterization have led to a greater understanding of its function and potential in various biological processes. Further research is needed to fully understand the protein's role in the body and its potential as a drug target and biomarker.

In conclusion, KLHL6 is a non-coding RNA molecule that has been identified in various organisms, including humans. Its function and structure have not yet been fully understood, but its potential as a drug target and biomarker is based on its unique ability to interact with small molecules and its structure and function. Further research is needed to fully understand the protein's role in the body and its potential as a drug target and biomarker.

Protein Name: Kelch Like Family Member 6

Functions: Involved in B-lymphocyte antigen receptor signaling and germinal center formation

The "KLHL6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KLHL6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets